The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells

被引:0
作者
D Saulep-Easton
F B Vincent
P S Quah
A Wei
S B Ting
C M Croce
C Tam
F Mackay
机构
[1] Monash University Central Clinical School,Department of Immunology
[2] Alfred Medical Research and Education Precinct (AMREP),Department of Haematology
[3] The Alfred Hospital,Division of Blood Cancers, Department of Medicine
[4] Australian Centre for Blood Diseases,Department of Molecular Virology
[5] Monash University Central Clinical School,Department of Haematology
[6] Alfred Medical Research and Education Precinct (AMREP),undefined
[7] Immunology and Medical Genetics,undefined
[8] The Ohio State University,undefined
[9] Peter MacCallum Cancer Centre,undefined
[10] St. Andrews’s Place,undefined
来源
Leukemia | 2016年 / 30卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Interleukin (IL)-10-producing B cells (B10 cells) have emerged as important regulatory elements with immunosuppressive roles. Chronic lymphocytic leukemia (CLL) B cells also secrete IL-10 and share features of B10 cells, suggesting a possible contribution of CLL B cells to immunosuppression in CLL patients. Factors controlling the emergence of B10 cells are not known. B-cell-activating factor of the tumor necrosis factor (TNF) family (BAFF) is critical for B-cell maturation and survival, and is implicated in the development and progression of CLL. We sought to investigate the role of BAFF in the emergence of IL-10-producing regulatory B cells in healthy donors and CLL patients. Here, we report that BAFF signaling promotes IL-10 production by CLL B cells in a mouse model of CLL and in CLL patients. Moreover, BAFF-mediated IL-10 production by normal and CLL B cells is mediated via its receptor transmembrane activator and cyclophilin ligand interactor. Our work uncovered a major targetable pathway important for the generation of regulatory B cells that is detrimental to immunity in CLL.
引用
收藏
页码:163 / 172
页数:9
相关论文
共 308 条
[21]  
Wasil T(2013)The BAFF/APRIL system: emerging functions beyond B cell biology and autoimmunity Cytokine Growth Factor Rev 24 203-215
[22]  
Fais F(2009)Cracking the BAFF code Nat Rev Immun 9 491-502
[23]  
Ghiotto F(2002)Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival Blood 100 2973-2979
[24]  
Valetto A(2010)Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells J Immunol 184 3321-3325
[25]  
Allen SL(1994)Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B-lymphocyte development Mol Cell Biol 14 3884-3894
[26]  
Rassenti LZ(2013)Polymorphisms of TNF and IL-10 genes and clinical outcome of patients with chronic lymphocytic leukemia Genes Chromosomes Cancer 52 287-296
[27]  
Jain S(2011)Combined analysis of levels of serum B-cell activating factor and a proliferation-inducing ligand as predictor of disease progression in patients with chronic lymphocytic leukemia Leukemia Lymphoma 52 2064-2068
[28]  
Keating MJ(2012)Soluble BAFF levels inversely correlate with peripheral B cell numbers and the expression of BAFF receptors J Immunol 188 497-503
[29]  
Wierda WG(2004)Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway Blood 103 679-688
[30]  
Grever MR(2000)BAFF mediates survival of peripheral immature B lymphocytes J Exp Med 192 1453-1466